Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Invested Capital (2017 - 2025)

Corcept Therapeutics' Return on Invested Capital history spans 9 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 8.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, down 8.0%, while the annual FY2025 figure was 0.1%, 10.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.1% at Corcept Therapeutics, down from 0.12% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.28% in Q1 2022 and bottomed at 0.1% in Q4 2025.
  • The 5-year median for Return on Invested Capital is 0.19% (2021), against an average of 0.19%.
  • The largest annual shift saw Return on Invested Capital grew 10bps in 2022 before it dropped -11bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.24% in 2021, then fell by -18bps to 0.2% in 2022, then dropped by -6bps to 0.19% in 2023, then decreased by -4bps to 0.18% in 2024, then tumbled by -42bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for CORT's Return on Invested Capital are 0.1% (Q4 2025), 0.12% (Q3 2025), and 0.16% (Q2 2025).